Innovating Works

H2020

Cerrada
HORIZON-CL4-2022-SPACE-01-13
End-to-end Earth observation systems and associated services
ExpectedOutcome:The expected outcomes of this topic will enable flexible satellite Earth-observation end-to-end systems, including the ground segment subsystem with explicit aspects of ground control centres and operations, as a strong subject of the "new space" and a very dynamic market environment with high potential. Competitiveness will be strengthened by providing growing capacity, as well as flexibility and agility to face uncertainties and market evolutions and improving system availability and latency to deliver high-quality experience to end-users.
Sólo fondo perdido 100%
Europeo
Mostrando 1 al 20 de 237 resultados
VORTEX SENSOR: Vortex microflow inducer that enables detection of ultra-low concentrations of species in sensors VRIJE UNIVERSITEIT BRUSSEL tramitó un HORIZON EUROPE: ERC-2022-POC2 According to WHO, in 2018, more than 100,000 chemicals were released into the global environment due to their production, use, and disposal....
2024-03-01 - 2025-08-31 | Financiado
R4R: R4R: Reproducible Data Analyses for All CESKE VYSOKE UCENI TECHNICKE V PRAZE tramitó un HORIZON EUROPE: ERC-2022-POC2 Unevaluated science is not worth funding. Gone are the days where a scientific breakthrough could be based on scribbles made on a few loose...
2024-01-01 - 2025-06-30 | Financiado
iSPEAK: iSPEAK: a Natural Language Processing Study in youth with subclinical psychotic experiences ROYAL COLLEGE OF SURGEONS IN IRELAND tramitó un HORIZON EUROPE: ERC-2022-POC2 Up to one fifth of young people report that they have experienced unusual perceptual experiences, thoughts or beliefs. These experiences (wh...
2024-01-01 - 2025-06-30 | Financiado
T-BAP: Targeting the Polycomb Machinery in BAP1-related Pathologies ISTITUTO EUROPEO DI ONCOLOGIA SRL tramitó un HORIZON EUROPE: ERC-2022-POC2 BAP1-related mutations are common genetic lesions of several cancers and neurodevelopmental disorders (NDDs). BAP1 is a deubiquitinase that...
2023-12-06 - 2025-06-30 | Financiado
LeukoScreen: AI-based leukemia detection in routine diagnostic blood smear data HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH tramitó un HORIZON EUROPE: ERC-2022-POC2 Acute promyelocytic leukemia is an extremely aggressive blood cancer where immediate diagnosis can determine life or death. The diagnostic s...
2023-11-03 - 2025-05-31 | Financiado
PAIN-CARE: Chronic PAIN eradiCAtion by taRgeting Schwann cElls FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS tramitó un HORIZON EUROPE: ERC-2022-POC2 About 25% of the adult population experiences chronic pain, which disrupts daily activities and severely affects the patient’s quality of li...
2023-11-01 - 2025-04-30 | Financiado
E-Virt: Virtual reality emotion training tool UNIVERSITEIT LEIDEN tramitó un HORIZON EUROPE: ERC-2022-POC2 The ERC starting grant project CoPAN (804582) is an innovative, interdisciplinary cross-boundary project. In the project, we study the funct...
2023-11-01 - 2025-04-30 | Financiado
PREDICT THE DRUG: Using ex vivo functional genomics as biomarker to predict the effectivity of Venetoclax in patients... HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH tramitó un HORIZON EUROPE: ERC-2022-POC2 For decades, oncologists treating cancer patients desire biomarkers that predict drug sensitivity on a patient individual level; unfortunate...
2023-10-26 - 2025-06-30 | Financiado
AQplus4: Deep Learning Air Quality Forecasts for Four Days FORSCHUNGSZENTRUM JULICH GMBH tramitó un HORIZON EUROPE: ERC-2022-POC2 AQplus4 will develop the first scientifically sound operational air quality forecasting system based on innovative deep learning and IT tech...
2023-10-24 - 2025-04-30 | Financiado
GNVISION: Gamma-Neutron Vision aimed at improved cancer treatments in Hadron Therapy AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS tramitó un HORIZON EUROPE: ERC-2022-POC2 Proton therapy represents one of the most recent and adavanced tools in cancer treatment, especially for complex cases and pediatric patient...
2023-10-05 - 2025-06-30 | Financiado
SusPlasMem: Sustainable Plasmonic Membranes for Water Remediation UNIVERSITAET POTSDAM tramitó un HORIZON EUROPE: ERC-2022-POC2 Plasmon chemistry is an emerging field in which light energy is converted into chemical energy or heat in metal nanoparticles (NPs). Previou...
2023-10-05 - 2025-06-30 | Financiado
BLASTOID-DISCOVERY: Human blastoids: a drug discovery platform for women’s reproductive health INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE GMBH tramitó un HORIZON EUROPE: ERC-2022-POC2 The first weeks of human pregnancy are crucial as early abnormalities or insults result in infertility. Therapeutics acting at the onset of...
2023-10-04 - 2025-04-30 | Financiado
CherPET: Cherenkov light for total-body Positron Emission Tomography INSTITUT JOZEF STEFAN tramitó un HORIZON EUROPE: ERC-2022-POC2 The paradigm shift in medicine from the treatment of acute or advanced disease to very early diagnosis and even prevention in cancer, as wel...
2023-10-01 - 2025-03-31 | Financiado
P3D Endoscopy: Polarized 3D Endoscopy TEL AVIV UNIVERSITY tramitó un HORIZON EUROPE: ERC-2022-POC2 The proliferation of artificial intelligence (AI) has led to a major advancement in many fields. It has enabled achieving non-precedent achi...
2023-10-01 - 2025-03-31 | Financiado
PROMETEO: PRoduction of an innOvative Millifluidic dEvice for TEsting of new prObiotics POLITECNICO DI MILANO tramitó un HORIZON EUROPE: ERC-2022-POC2 Over the last decades, the gut intestinal microflora and other microbial communities present in our body raised a strong interest in the hea...
2023-10-01 - 2025-03-31 | Financiado
CELL-FORCE: Validation of a novel device for real-time, long-term measurement of cellular forces UNIVERSITAT ZU KOLN tramitó un HORIZON EUROPE: ERC-2022-POC2 The conventional thinking in cell biology, which often assumes that cells communicate mostly via bio-chemical signalling, has recently been...
2023-09-14 - 2025-06-30 | Financiado
longCOVID-UVBtherapy: Phototherapy treatment for long-term COVID-19 patients TEL AVIV UNIVERSITY tramitó un HORIZON EUROPE: ERC-2022-POC2 As the number of COVID-19 cases grows worldwide, so does the number of those suffering from clinical parameters that last weeks to-months po...
2023-09-01 - 2025-02-28 | Financiado
versacomb: Versatile optical frequency comb UNIVERSITE LIBRE DE BRUXELLES tramitó un HORIZON EUROPE: ERC-2022-POC2 Frequency combs are optical sources that can be used as rulers. Any unknown frequency can be very precisely measured by comparing it to the...
2023-09-01 - 2025-02-28 | Financiado
LGSMAIZE: Engineering of low germination stimulant production to control witchweed infection in maize in Sub-S... UNIVERSITEIT VAN AMSTERDAM tramitó un HORIZON EUROPE: ERC-2022-POC2 The parasitic witchweeds, such as Striga hermonthica and Striga asiatica, pose an enormous threat for production of cereal crops, such as so...
2023-09-01 - 2025-02-28 | Financiado
SOCIAbLE: Social Cognitive Interventions following Adverse early Life Experiences UNIVERSITY OF GALWAY tramitó un HORIZON EUROPE: ERC-2022-POC2 The affective and cognitive consequences of childhood trauma are experienced across the life span, and are associated with poorer mental and...
2023-09-01 - 2025-02-28 | Financiado